ā­ļøā­ļøā­ļøā­ļøā­ļø "A total no brainer"

ā­ļøā­ļøā­ļøā­ļøā­ļø "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for vinorelbine tartrate oral

Every month we try and update this database with for vinorelbine tartrate oral cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast CancerNCT06255392
Breast Cancer
Fluzoparib
Apatinib Mesyla...
Capecitabine ta...
Vinorelbine Tar...
Eribulin mesyla...
Gemcitabine Hyd...
Paclitaxel-albu...
18 Years - 70 YearsSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative ChemotherapyNCT03703427
Pathologic Resi...
Capecitabine, O...
Vinorelbine Tar...
20 Years - 75 YearsShandong Cancer Hospital and Institute
Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast CancerNCT06255392
Breast Cancer
Fluzoparib
Apatinib Mesyla...
Capecitabine ta...
Vinorelbine Tar...
Eribulin mesyla...
Gemcitabine Hyd...
Paclitaxel-albu...
18 Years - 70 YearsSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: